All news from Anaesthesiology

Revolutionary Model Made Study of Pulmonary Diseases Easy

Researchers at the University of Arizona College of Medicine – Phoenix have developed a revolutionary "lung on a leaf" to study pulmonary diseases.Researchers have received a three-year, $750,000 grant from the Arizona Biomedical Research Commission to study lung infections like Valley fever and inflammatory conditions like sarcoidosis in a plant model.

Stroke: Motor Recovery Boosted With Dual-Therapy

Paralysis of an arm and/or leg is one of the most common effects of a stroke. But thanks to research carried out by scientists at the Defitech Foundation Chair in Brain-Machine Interface and collaborators, stroke victims may soon be able to recover greater use of their paralyzed limbs. The scientists' pioneering approach brings together two known types of therapies—a brain-computer interface (BCI) and functional electrical stimulation (FES) – and has been published in Nature Communications.

Cardiac Arrest: Deaths are Misclassified, Overestimated

Forty percent of deaths attributed to cardiac arrest are not sudden or unexpected, and nearly half of the remainder are not arrhythmic—the only situation in which CPR and defibrillators are effective—according to an analysis by researchers at UC San Francisco and the City and County of San Francisco Office of the Chief Medical Examiner. The study appears in the special autopsy issue of the American Heart Association journal Circulation.

Phase II Clinical Trial on Namodenoson, New Update Provided

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, provided an update on its Phase II clinical trial with drug candidate Namodenoson (CF102) in the treatment of advanced hepatocellular carcinoma (HCC) in patients whose disease has progressed on sorafenib therapy. Can-Fite anticipates analyzing the results of this important trial before the end of the current year.